ARCHIVES

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

McKesson To Purchase US Oncology

November 5, 2010

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

November 6, 1981

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001